Pulmonology

Your Article Summary

See Latest Articles

Pemetrexed for the treatment of non-small-cell lung cancer
Expert Review of Anticancer Therapy, 09/24/09

Manegold C et al. – Pemetrexed is a novel multi–targeted antifolate that is used in the treatment of both malignant pleural mesothelioma and non–small–cell lung cancer (NSCLC). Ongoing trials aim to establish the place of pemetrexed in maintenance, in combination with other ‘targeted agents’, in adjuvant therapy in early NSCLC and in concurrent radio/chemotherapy.

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

A Randomized Trial of Nebulized 3% Hypertonic Saline With Epinephrine in the Treatment of Acute Bronchiolitis in the Emergency Department
Archives of Pediatrics and Adolescent Medicine, 11/23/09

An Umbrella Review: Corticosteroid Therapy for Adults with Acute Asthma
American Journal of Medicine, 10/27/09

Clinical Studies of Combination Montelukast and Loratadine in Patients with Seasonal Allergic Rhinitis
Journal of Asthma, 11/11/09

See All of Clinical Pharmacology

Today in Lung/Thoracic Oncology...keeping you current

Receive free subspecialty "5-minute updates" via email

Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer
Journal of Clinical Oncology, 11/05/09

Tumor necrosis factor inhibitors and lung disease: A paradox of efficacy and risk
Seminars in Arthritis and Rheumatism, 11/20/09

Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial
Lung Cancer, 11/03/09

See All of Lung/Thoracic Oncology